These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9838500)

  • 1. Diversity of gene expression following heart transplantation in rats.
    Han DJ; We YM; Kang HY; Lee JH
    Transplant Proc; 1998 Nov; 30(7):3405-6. PubMed ID: 9838500
    [No Abstract]   [Full Text] [Related]  

  • 2. Apoptosis in rat cardiac allograft rejection.
    Kageyama Y; Li XK; Suzuki S; Suzuki H; Suzuki K; Kazui T; Harada Y
    Transplant Proc; 1998 Nov; 30(7):2943. PubMed ID: 9838297
    [No Abstract]   [Full Text] [Related]  

  • 3. Identification of alterations in gene expression in rat recipients with long-term-surviving cardiac grafts.
    Lu H; Zhang HQ; Enosawa S; Suzuki S
    Transplant Proc; 2002 Nov; 34(7):2729-31. PubMed ID: 12431588
    [No Abstract]   [Full Text] [Related]  

  • 4. Thymic and liver graft expression of CD95-L tolerizes allogeneic orthotopic liver grafts.
    Fändrich F; Lin X; Huang DS; Zhu X; Parwaresch R; Kremer B; Henne-Bruns D
    Transplant Proc; 1999; 31(1-2):438-9. PubMed ID: 10083178
    [No Abstract]   [Full Text] [Related]  

  • 5. Apoptosis is involved in acute cardiac allograft rejection in rats.
    Kageyama Y; Li XK; Suzuki S; Suzuki H; Suzuki K; Kazui T; Harada Y
    Ann Thorac Surg; 1998 Jun; 65(6):1604-9. PubMed ID: 9647066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implication of monocyte/macrophage infiltration into the graft following heart transplantation in rats.
    Han DJ; Kim SC; Lee HM; We YM; Kang HY; Yu ES
    Transplant Proc; 1998 Nov; 30(7):3407. PubMed ID: 9838501
    [No Abstract]   [Full Text] [Related]  

  • 7. Early detection of the Fas-FasL system in hepatic graft-versus-host disease after rat small-bowel transplantation.
    Shiraishi M; Hiroyasu S; Koji T; Muto Y; Koyama Y
    Transplant Proc; 1999; 31(1-2):567-8. PubMed ID: 10083239
    [No Abstract]   [Full Text] [Related]  

  • 8. FTY720 inhibits the mRNA expression of intragraft cytotoxic molecules, leading to cardiac allograft survival.
    Nakajima H; Sun E; Mizuta N; Fujiwara I; Oka T
    Transplant Proc; 1998 Aug; 30(5):2217-20. PubMed ID: 9723446
    [No Abstract]   [Full Text] [Related]  

  • 9. Cellular surface molecular and cytokine gene expression in rat heart allografts under optimal doses of cyclosporine and FK 506.
    Fujimura T; Yang XF; Soriano R; Ogawa T; Kobayashi M; Jiang H
    Transplant Proc; 1998 Jun; 30(4):1023-6. PubMed ID: 9636413
    [No Abstract]   [Full Text] [Related]  

  • 10. Chemokine profile during allogeneic heart transplant rejection.
    Saber LT; Aliberti JC; Silva JS; Rossi MA; Ferraz AS
    Transplant Proc; 1999 Nov; 31(7):2978-81. PubMed ID: 10578356
    [No Abstract]   [Full Text] [Related]  

  • 11. Early detection of apoptosis and fas ligand expression in hepatic graft-versus-host disease after rat small bowel transplantation.
    Shiraishi M; Hiroyasu S; Oshiro T; Nagahama M; Tomori H; Mamadi T; Muto Y
    J Surg Res; 1999 Sep; 86(1):136-44. PubMed ID: 10452880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD95L confers immune priviledge to liver grafts which are spontaneously accepted.
    Fändrich F; Lin X; Zhu X; Klöppel G; Parwaresch R; Kremer B
    Transplant Proc; 1998 Jun; 30(4):1057-8. PubMed ID: 9636427
    [No Abstract]   [Full Text] [Related]  

  • 13. Allopeptide-mediated expression of endothelial Fas-ligand (CD95L) in long-term tolerized heterotopic rat heart grafts.
    Fändrich F; Dresske B; Lin X; Huang DS; Zavazava N; Henne-Bruns D
    Transplant Proc; 1999 May; 31(3):1558-9. PubMed ID: 10330999
    [No Abstract]   [Full Text] [Related]  

  • 14. Bioelectrical tissue resistance in the heterotopic rat heart transplant model.
    Kuinose M; Tanaka N; Orita K
    Transplant Proc; 1996 Jun; 28(3):1836-8. PubMed ID: 8658907
    [No Abstract]   [Full Text] [Related]  

  • 15. Gene expression profiling of acute rejection and mixed lymphocyte reaction with tacrolimus immunosuppression.
    Erickson L; Crews G; Pan F; Kobayashi M; Jiang H
    Transplant Proc; 2002 Aug; 34(5):1385-6. PubMed ID: 12176407
    [No Abstract]   [Full Text] [Related]  

  • 16. Fas ligand gene transfer prolongs rat renal allograft survival and down-regulates anti-apoptotic Bag-1 in parallel with enhanced Th2-type cytokine expression.
    Ke B; Coito AJ; Kato H; Zhai Y; Wang T; Sawitzki B; Seu P; Busuttil RW; Kupiec-Weglinski JW
    Transplantation; 2000 Apr; 69(8):1690-4. PubMed ID: 10836382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolerance induction following orthotopic rat liver transplantation: cytokine production by CD4+ T cells determines the immunological response.
    Gassel HJ; Kauczock J; Martens N; Steger U; Timmermann W; Ulrichs K; Otto C
    Transplant Proc; 2002 Aug; 34(5):1429-30. PubMed ID: 12176426
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of hemodynamics on graft rejection in the heterotopic heart transplantation model.
    Lange V; Gassel AM; Deuse T; Ulrichs K; Silber RE
    Transplant Proc; 1998 Jun; 30(4):1014-6. PubMed ID: 9636410
    [No Abstract]   [Full Text] [Related]  

  • 19. Prolonged survival of recipient rats with Fas-ligand-transfected liver allografts by using HVJ-liposome.
    Li XK; Okuyama T; Tamura A; Fujino M; Funeshima N; Kaneda Y; Kita Y; Enosawa S; Amemiya H; Suzuki S
    Transplant Proc; 1998 Jun; 30(4):943. PubMed ID: 9636379
    [No Abstract]   [Full Text] [Related]  

  • 20. Correlation of Fas and Fas ligand expression with rejection status of transplanted heart in human.
    Oh SI; Kim IW; Jung HC; Seo JW; Chae IH; Kim HS; Oh BH
    Transplantation; 2001 Apr; 71(7):906-9. PubMed ID: 11349725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.